Literature DB >> 9870547

The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation.

T Yokota1, H Nishio, Y Kubota, M Mizoguchi.   

Abstract

Glabridin is the main ingredient in hydrophobic fraction of licorice extract affecting on skins. In this study, we investigated inhibitory effects of glabridin on melanogenesis and inflammation using cultured B16 murine melanoma cells and guinea pig skins. The results indicated that glabridin inhibits tyrosinase activity of these cells at concentrations of 0.1 to 1.0 microg/ml and had no detectable effect on their DNA synthesis. Combined analysis of SDS-polyacrylamide gel electrophoresis and DOPA staining on the large granule fraction of these cells disclosed that glabridin decreased specifically the activities of T1 and T3 tyrosinase isozymes. It was also shown that UVB-induced pigmentation and erythema in the skins of guinea pigs were inhibited by topical applications of 0.5% glabridin. Anti-inflammatory effects of glabridin in vitro were also shown by its inhibition of superoxide anion productions and cyclooxygenase activities. These data indicated that glabridin is a unique compound possessing more than one function; not only the inhibition of melanogenesis but also the inhibition of inflammation in the skins. By replacing each of hydroxyl groups of glabridin with others, it was revealed that the inhibitory effect of 2'-O-ethyl glabridin was significantly stronger than that of 4'-O-ethyl-glabridin on melanin synthesis in cultured B16 cells at the concentration of 1.0 mg/ml. With replacement of both of two hydroxyl groups, the inhibitory effect was totally lost. Based on these data, we concluded that two hydroxyl groups of glabridin are important for the inhibition of melanin synthesis and that the hydroxyl group at the 4' position of this compound is more closely related to melanin synthesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9870547     DOI: 10.1111/j.1600-0749.1998.tb00494.x

Source DB:  PubMed          Journal:  Pigment Cell Res        ISSN: 0893-5785


  38 in total

1.  Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color.

Authors:  Erica C Davis; Valerie D Callender
Journal:  J Clin Aesthet Dermatol       Date:  2010-07

2.  [Methods and means for pigmentation and depigmentation. Sense or nonsense?].

Authors:  V Hegyi; J Hegyi
Journal:  Hautarzt       Date:  2010-07       Impact factor: 0.751

Review 3.  The Tricky Tear Trough: A Review of Topical Cosmeceuticals for Periorbital Skin Rejuvenation.

Authors:  Stacey J Pilkington; Sarah Belden; Richard A Miller
Journal:  J Clin Aesthet Dermatol       Date:  2015-09

4.  Multi-pathway integrated adjustment mechanism of licorice flavonoids presenting anti-inflammatory activity.

Authors:  Xiaomeng Yu; Yongrui Bao; Xiansheng Meng; Shuai Wang; Tianjiao Li; Xin Chang; Weifeng Xu; Guanlin Yang; Tao Bo
Journal:  Oncol Lett       Date:  2019-09-04       Impact factor: 2.967

5.  Hydroquinone-free Skin Brightener System for the Treatment of Moderate-to-severe Facial Hyperpigmentation.

Authors:  James H Herndon; Elizabeth T Makino; Thomas J Stephens; Rahul C Mehta
Journal:  J Clin Aesthet Dermatol       Date:  2014-05

6.  Mixed-type inhibition of tyrosinase from Agaricus bisporus by terephthalic acid: computational simulations and kinetics.

Authors:  Shang-Jun Yin; Yue-Xiu Si; Yong-Fu Chen; Guo-Ying Qian; Zhi-Rong Lü; Sangho Oh; Jinhyuk Lee; Sanghyuk Lee; Jun-Mo Yang; Dong-Youn Lee; Yong-Doo Park
Journal:  Protein J       Date:  2011-04       Impact factor: 2.371

Review 7.  Are Natural Ingredients Effective in the Management of Hyperpigmentation? A Systematic Review.

Authors:  Jasmine C Hollinger; Kunal Angra; Rebat M Halder
Journal:  J Clin Aesthet Dermatol       Date:  2018-02-01

8.  Induction of melanogenesis by 4'-O-methylated flavonoids in B16F10 melanoma cells.

Authors:  Ippei Horibe; Yudai Satoh; Yuki Shiota; Ayako Kumagai; Nanao Horike; Hiroshi Takemori; Shinichi Uesato; Shuji Sugie; Katsuyoshi Obata; Hidehisa Kawahara; Yasuo Nagaoka
Journal:  J Nat Med       Date:  2012-12-04       Impact factor: 2.343

9.  Topical treatment of melasma.

Authors:  Debabrata Bandyopadhyay
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

Review 10.  An updated review of tyrosinase inhibitors.

Authors:  Te-Sheng Chang
Journal:  Int J Mol Sci       Date:  2009-05-26       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.